Tenaya Therapeutics has established strategic academic collaborations and industry partnerships with leading research institutions to accelerate its cardiovascular drug discovery and target validation pipelines. Key foundational relationships include institutional research collaborations with the Gladstone Institutes and the University of Texas Southwestern Medical Center, alongside various specialized scientific networks aimed at advancing its gene replacement therapies, cellular regeneration programs, and precision medicine initiatives.